Bellozal 20 mg orodisp. tabl.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Bilastine 20 mg
Available from:
Menarini International Operations Luxembourg S.A.
ATC code:
R06AX29
Pharmaceutical form:
Orodispersible tablet
Administration route:
Oral use
Therapeutic area:
Bilastine
Product summary:
CTI Extended: 661446-02; 661446-04; 661446-01; 661446-03; 661446-05
Authorization status:
Commercialised: No
Authorization date:
2023-05-11
